PGT-M conditions
This table shows all PGT-M conditions currently approved and awaiting consideration by the HFEA.
Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact pgtm@hfea.gov.uk.
Download full approved condition list.
Condition name | Status | OMIM number | Documents |
---|---|---|---|
Macrocephaly, dysmorphic facies, and psychomotor retardation (MDFPMR) | approved | 617011 | |
Mal De Meleda (MDM) | approved | 248300 | |
Malignant Infantile Osteopetrosis | approved | 259700 | |
Mandibuloacral Dysplasia with Type A Lipodystrophy; MADA | awaiting approval | 248370 | |
Maple Syrup Urine Disorder (MSUD) | approved | 248600 | |
Marfan Syndrome (MFS) | approved | 154700 | |
Meckel-Gruber Syndrome Types 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 and 11 | approved | 249000, 603194, 607361, 611134, 611561, 612284, 267010, 613885, 614209, 614175 and 615397 | |
Medium-Chain Acyl-CoA Dehydrogenase Deficiency | approved | 201450 | |
Medullary Cystic Kidney Disease 2 (MCKD2) (also known as Autosomal Dominant Tubulointerstitial Kidney Disease due to Uromodulin Mutations (ADTKD-UMOD) | approved | 603860 | |
Megaloblastic Anemia due to Dihydrofolate Reductase Deficiency (DHFR) | approved | 613839 | |
MEGDEL syndrome (3-Methylglutaconic Aciduria with Deafness, Encephalopathy, and Leigh-Like Syndrome) | approved | 614739 | |
MEHMO Syndrome; MEHMO | approved | 300148 | |
Melanoma Pancreatic Cancer Syndrome | approved | 606719 | |
Melanoma, cutaneous malignant, susceptibility to, 10 (CMM10) | approved | 615848 | |
Melanoma, cutaneous malignant, susceptibility to, 2 (CMM2) | approved | 155601 | |
Melanoma, cutaneous malignant, susceptibility to, 3 (CMM3) | approved | 609048 | |
Melanoma-Astrocytoma Syndrome | approved | 155755 | |
MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes) | approved | 540000 | |
Melnick Needles Syndrome | approved | 309350 | |
Menkes disease | approved | 309400 |